Ziprasidone - CAS# 146939-27-7 10171 AI-10-49 restores RUNX1 transcriptional activity

AI-10-49 restores RUNX1 transcriptional activity

Drug Des Devel Ther

ClH/c6-3-4(7)1-2-5(8)9

Chemical Name: (E)-2-((3-aminopyridin-2-yl)methylene)hydrazinecarbothioamide

These studies support the potential utility of AMG 837 for the treatment of type 2 diabetes

Ziprasidone - CAS# 146939-27-7 10171 AI-10-49 restores RUNX1 transcriptional activityZiprazidone is approved for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate. The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown. However, it has been proposed that this drug's efficacy in schizophrenia